Keratoacanthoma: The Rapidly Growing Skin Tumor That May Resolve on Its Own

Keratoacanthoma (KA) is a common skin tumor that arises from hair follicle cells and is characterized by its remarkably rapid growth. It typically appears as a dome-shaped, flesh-colored nodule with a central keratin-filled crater, giving it a distinctive volcano-like appearance. Keratoacanthomas most commonly occur on sun-exposed skin in older adults, particularly on the face, forearms, and hands. The tumor's relationship to squamous cell carcinoma remains a subject of ongoing debate in dermatology, with many experts considering KA to be a low-grade variant of squamous cell carcinoma rather than a truly benign growth.

One of the most distinctive features of keratoacanthoma is its predictable three-phase growth cycle. During the proliferative phase, which typically lasts two to four weeks, the tumor grows rapidly, sometimes reaching one to two centimeters in diameter. This is followed by a maturation or stationary phase where growth plateaus and the lesion maintains its characteristic dome shape with a central keratin plug. In many cases, a spontaneous involution phase follows, during which the tumor gradually shrinks and may eventually disappear completely over several months, often leaving a depressed scar.

The primary risk factor for developing keratoacanthoma is chronic ultraviolet radiation exposure, which explains its predilection for sun-exposed areas of the body. The condition is most common in fair-skinned individuals over the age of 50, and men are affected more frequently than women. Immunosuppression, whether from medications such as those taken by organ transplant recipients or from conditions like HIV, significantly increases the risk. Other associated factors include exposure to certain chemical carcinogens, trauma or surgery sites, and human papillomavirus infection.

The distinction between keratoacanthoma and squamous cell carcinoma is one of the most challenging diagnostic dilemmas in dermatopathology. Both tumors can appear very similar clinically and microscopically, and some pathologists classify KA as a subtype of well-differentiated squamous cell carcinoma rather than a separate entity. The key clinical difference is the growth pattern: keratoacanthomas typically grow much more rapidly and may spontaneously regress, whereas squamous cell carcinomas grow more slowly and progressively. Because it is not always possible to distinguish the two with certainty, most dermatologists recommend treating keratoacanthoma as if it were a squamous cell carcinoma to avoid the risk of an invasive cancer being left untreated.!!

Diagnosing keratoacanthoma requires both clinical assessment and histopathological examination. The characteristic rapid growth, dome shape, and central keratin crater provide important clinical clues, but a biopsy is essential for confirmation. An excisional biopsy that includes the full depth and architecture of the lesion is preferred, as a small punch biopsy may not capture enough tissue to distinguish KA from squamous cell carcinoma. The pathologist looks for specific architectural features including a crateriform or cup-shaped silhouette, well-differentiated squamous cells, and the characteristic central keratin plug.

Despite the potential for spontaneous regression, most dermatologists recommend active treatment of keratoacanthoma rather than watchful waiting.!! Surgical excision is the most common and reliable treatment, providing both complete removal and tissue for pathological analysis. Mohs micrographic surgery may be used for lesions on cosmetically sensitive areas like the face, as it allows for maximum tissue conservation while ensuring complete removal. Alternative treatments for patients who cannot undergo surgery include intralesional injections of methotrexate or 5-fluorouracil, topical treatments, and radiation therapy.

The prognosis for keratoacanthoma is generally excellent when the lesion is properly treated. Surgical excision has a very high cure rate, and recurrence after complete removal is uncommon. Even without treatment, many keratoacanthomas will eventually regress on their own, though this process can take months and may leave a significant scar. The rare cases of concern are those involving perineural invasion or aggressive growth patterns, which may behave more like conventional squamous cell carcinoma and require more extensive treatment.

Individuals who have had one keratoacanthoma are at increased risk for developing additional lesions as well as other forms of skin cancer, making ongoing monitoring essential. Regular professional skin examinations and diligent sun protection are recommended for anyone with a history of KA. Skinscanner can be a valuable tool for tracking new or changing skin growths between dermatology visits, helping you notice the rapid growth pattern that is characteristic of keratoacanthoma. Any rapidly growing skin nodule should prompt an immediate visit to a dermatologist for evaluation, as early intervention leads to the best cosmetic and medical outcomes.